Evidence map›Paper›PMID 23837398›Full record

ArticleOrphanet journal of rare diseases2013

Phenotypic and functional consequences of haploinsufficiency of genes from exocyst and retinoic acid pathway due to a recurrent microdeletion of 2p13.2.

Jiadi Wen, Fátima Lopes, Gabriela Soares, Sandra A Farrell, Cara Nelson, Ying Qiao, Sally Martell, Chansonette Badukke, Carlos Bessa, Bauke Ylstra and 4 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Knockout of Cyp26a1 and Cyp26b1 during postnatal life causes reduced lifespan, dermatitis, splenomegaly, and systemic inflammation in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Accelerated Skeletal Maturation in Disorders of Retinoic Acid Metabolism: A Case Report and Focused Review of the Literature.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2016
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. FOXP2, retinoic acid, and language: a promising direction.Frontiers in cellular neuroscience · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Jiadi WenChild and Family Research Institute, Department of Pathology, University of British Columbia, Vancouver, BC, Canada.
Fátima Lopes
Gabriela Soares
Sandra A Farrell
Cara Nelson
Ying Qiao
Sally Martell
Chansonette Badukke
Carlos Bessa
Bauke Ylstra
Suzanne Lewis
Nina Isoherranen
Patricia Maciel
Evica Rajcan-Separovic
University of British Columbia · CAUniversity of Minho · PTUniversity of Washington · USAmsterdam UMC Location Vrije Universiteit Amsterdam · NLChild and Family Research Institute · CATrillium Health Centre · CA

Funding

Effects of Xenobiotics on CYP26 Activity and Retinoic Acid HomeostasisR01GM081569 · NIGMS · UNIVERSITY OF WASHINGTON · PI ISOHERRANEN, NINA · 2008 to 2012
$1.7M
CIHR MOP 74502CIHR RT-64217NIGMS NIH HHS R01 GM081569Wellcome Trust
6 · The paper itself

Abstract

backgroundRare, recurrent genomic imbalances facilitate the association of genotype with abnormalities at the "whole body" level. However, at the cellular level, the functional consequences of recurrent genomic abnormalities and how they can be linked to the phenotype are much less investigated. METHOD AND

resultsWe report an example of a functional analysis of two genes from a new, overlapping microdeletion of 2p13.2 region (from 72,140,702-72,924,626). The subjects shared intellectual disability (ID), language delay, hyperactivity, facial asymmetry, ear malformations, and vertebral and/or craniofacial abnormalities. The overlapping region included two genes, EXOC6B and CYP26B1, which are involved in exocytosis/Notch signaling and retinoic acid (RA) metabolism, respectively, and are of critical importance for early morphogenesis, symmetry as well as craniofacial, skeleton and brain development. The abnormal function of EXOC6B was documented in patient lymphoblasts by its reduced expression and with perturbed expression of Notch signaling pathway genes HES1 and RBPJ, previously noted to be the consequence of EXOC6B dysfunction in animal and cell line models. Similarly, the function of CYP26B1 was affected by the deletion since the retinoic acid induced expression of this gene in patient lymphoblasts was significantly lower compared to controls (8% of controls).

conclusionHaploinsufficiency of CYP26B1 and EXOC6B genes involved in retinoic acid and exocyst/Notch signaling pathways, respectively, has not been reported previously in humans. The developmental anomalies and phenotypic features of our subjects are in keeping with the dysfunction of these genes, considering their known role. Documenting their dysfunction at the cellular level in patient cells enhanced our understanding of biological processes which contribute to the clinical phenotype.

Indexed as

Chromosome DeletionHaploinsufficiencyAbnormalities, MultipleAdolescentBone Diseases, DevelopmentalCell LineChildChromosomes, Human, Pair 2Craniofacial AbnormalitiesCytochrome P-450 Enzyme SystemDevelopmental DisabilitiesExocytosisGenotypeGTP-Binding ProteinsHumansMaleCYP26B1 protein, humanCytochrome P-450 Enzyme SystemEXOC6B protein, humanGTP-Binding ProteinsRetinoic Acid 4-HydroxylaseTretinoin

Identifiers

PMID23837398
PMCPMC3710273
OpenAlexW2102040294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.